In 2022, Senator Breslin introduced S8191, and Assemblyman McDonald introduced A9267 to create additional step-therapy patient protections, such as prohibiting patients from step through off-label medications, requiring patients to try and fail on more than one drug, or requiring step therapy for longer than 30 days. Read the fact sheet here.
Last Updated on September 29, 2023 by Aimed Alliance
